FibroScan-AST (FAST) score for the non-invasive identification of patients with non-alcoholic steatohepatitis with significant activity and fibrosis: a prospective derivation and global validation study - Concepedia

Concepedia

Publication | Open Access

FibroScan-AST (FAST) score for the non-invasive identification of patients with non-alcoholic steatohepatitis with significant activity and fibrosis: a prospective derivation and global validation study

DOI Full Paper Access

729

Citations

21

References

2020

Year

Philip N. Newsome, M. Sasso, Jonathan J Deeks, Angelo H. Paredes, Jérôme Boursier, Wah‐Kheong Chan, Yusuf Yılmaz, Sébastien Czernichow, Ming‐Hua Zheng, Vincent Wai‐Sun Wong,

The Lancet. Gastroenterology & hepatology

Abstract

Echosens and UK National Institute for Health Research.

References

	Year	Citations
Design and validation of a histological scoring system for nonalcoholic fatty liver disease† David E. Kleiner, Elizabeth M. Brunt, Mark L. Van Natta, Hepatology Nafld Activity ScoreDiagnosisPathologyGastroenterologyFatty Liver Disease	2005	10.5K
Transparent Reporting of a multivariable prediction model for Individual Prognosis Or Diagnosis (TRIPOD): Explanation and Elaboration Karel G.M. Moons, Douglas G. Altman, Johannes B. Reitsma, Annals of Internal Medicine EngineeringPrognosisDiagnosisPrognosticsPatient-reported Outcome	2015	4.9K
Transparent reporting of a multivariable prediction model for individual prognosis or diagnosis (TRIPOD): the TRIPOD statement Gary S. Collins, Johannes B. Reitsma, Douglas G. Altman, BMJ EngineeringPrognosisDiagnosisIndividual PrognosisPatient-reported Outcome	2015	3.7K
The NAFLD fibrosis score Paul Angulo, Jason M. Hui, Giulio Marchesini, Hepatology	2007	3.1K
Liver Fibrosis, but No Other Histologic Features, Is Associated With Long-term Outcomes of Patients With Nonalcoholic Fatty Liver Disease Paul Angulo, David E. Kleiner, Sanne Dam‐Larsen, Gastroenterology Metabolic Associated SteatohepatitisFibrosisHepatologyLiver FibrosisNonalcoholic Fatty Liver Disease	2015	2.9K
Transient elastography: a new noninvasive method for assessment of hepatic fibrosis Laurent Sandrin, Bertrand Fourquet, Jean-Michel Hasquenoph, Ultrasound in Medicine & Biology New Noninvasive MethodMedical UltrasoundHepatologyMedical ImagingLiver Physiology	2003	2.7K
Fibrosis stage is the strongest predictor for disease‐specific mortality in NAFLD after up to 33 years of follow‐up Mattias Ekstedt, Hannes Hagström, Patrik Nasr, Hepatology	2014	2.2K
Accuracy of FibroScan Controlled Attenuation Parameter and Liver Stiffness Measurement in Assessing Steatosis and Fibrosis in Patients With Nonalcoholic Fatty Liver Disease Peter Eddowes, M. Sasso, Michael Allison, Gastroenterology HepatologyLiver Stiffness MeasurementNonalcoholic Fatty Liver DiseaseLiver PhysiologyAssessing Steatosis	2019	1.3K
Frequency and Outcomes of Liver Transplantation for Nonalcoholic Steatohepatitis in the United States Michael Charlton, Justin M. Burns, Rachel Pedersen, Gastroenterology HepatologyNonalcoholic Fatty Liver DiseaseSolid Organ TransplantationNonalcoholic SteatohepatitisLiver Disease	2011	1.1K
Elafibranor, an Agonist of the Peroxisome Proliferator−Activated Receptor−α and −δ, Induces Resolution of Nonalcoholic Steatohepatitis Without Fibrosis Worsening Vlad Ratziu, Stephen A. Harrison, Sven Francque, Gastroenterology	2016	993

Page 1